Han-Jou Chen

1.3k total citations
10 papers, 765 citations indexed

About

Han-Jou Chen is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Han-Jou Chen has authored 10 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Han-Jou Chen's work include Amyotrophic Lateral Sclerosis Research (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Prion Diseases and Protein Misfolding (3 papers). Han-Jou Chen is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (9 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Prion Diseases and Protein Misfolding (3 papers). Han-Jou Chen collaborates with scholars based in United Kingdom, Slovenia and Italy. Han-Jou Chen's co-authors include Christopher E. Shaw, Agnes L. Nishimura, Jacqueline C. Mitchell, Emma L. Scotter, Caroline Vance, Youn‐Bok Lee, Boris Rogelj, Valentina Sardone, David C. Rubinsztein and Hazel Urwin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain.

In The Last Decade

Han-Jou Chen

9 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han-Jou Chen United Kingdom 8 528 422 259 138 115 10 765
Mark A. Halloran Australia 6 464 0.9× 250 0.6× 207 0.8× 154 1.1× 91 0.8× 8 673
Sadaf T. Warraich Australia 12 629 1.2× 375 0.9× 322 1.2× 129 0.9× 131 1.1× 12 825
Alyssa N. Coyne United States 13 559 1.1× 713 1.7× 337 1.3× 119 0.9× 165 1.4× 23 992
Allison Citro United States 5 480 0.9× 720 1.7× 233 0.9× 119 0.9× 142 1.2× 6 1.0k
Jacqueline Dols Germany 8 408 0.8× 445 1.1× 236 0.9× 80 0.6× 165 1.4× 8 788
Hazel Urwin United Kingdom 5 485 0.9× 333 0.8× 206 0.8× 143 1.0× 92 0.8× 5 712
Nandini Ramesh United States 13 332 0.6× 352 0.8× 176 0.7× 80 0.6× 105 0.9× 14 566
Amanda M. Gleixner United States 15 300 0.6× 492 1.2× 159 0.6× 72 0.5× 96 0.8× 20 714
Christopher P Webster United Kingdom 10 370 0.7× 221 0.5× 162 0.6× 90 0.7× 96 0.8× 12 579
Ruxandra Dafinca United Kingdom 9 453 0.9× 367 0.9× 231 0.9× 48 0.3× 141 1.2× 15 636

Countries citing papers authored by Han-Jou Chen

Since Specialization
Citations

This map shows the geographic impact of Han-Jou Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-Jou Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-Jou Chen more than expected).

Fields of papers citing papers by Han-Jou Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han-Jou Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-Jou Chen. The network helps show where Han-Jou Chen may publish in the future.

Co-authorship network of co-authors of Han-Jou Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Han-Jou Chen. A scholar is included among the top collaborators of Han-Jou Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han-Jou Chen. Han-Jou Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ho, Andrew, Fiona Jeganathan, Magda Bictash, & Han-Jou Chen. (2025). Identification of novel small molecule chaperone activators for neurodegenerative disease treatment. Biomedicine & Pharmacotherapy. 187. 118049–118049.
2.
Chen, Han-Jou & Jacqueline C. Mitchell. (2021). Mechanisms of TDP-43 Proteinopathy Onset and Propagation. International Journal of Molecular Sciences. 22(11). 6004–6004. 15 indexed citations
3.
Chen, Han-Jou, Simon Topp, Elsa Zacco, et al.. (2019). RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Brain. 142(12). 3753–3770. 68 indexed citations
4.
Lee, Youn‐Bok, Han-Jou Chen, Agnes L. Nishimura, et al.. (2017). C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Human Molecular Genetics. 26(24). 4765–4777. 65 indexed citations
5.
Chen, Han-Jou, Jacqueline C. Mitchell, Sergey S. Novoselov, et al.. (2016). The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 139(5). 1417–1432. 132 indexed citations
6.
Scotter, Emma L., Caroline Vance, Agnes L. Nishimura, et al.. (2014). Differential roles of the ubiquitin proteasome system (UPS) and autophagy in the clearance of soluble and aggregated TDP-43 species. Journal of Cell Science. 127(Pt 6). 1263–78. 211 indexed citations
7.
Nishimura, Agnes L., Carole Shum, Emma L. Scotter, et al.. (2014). Allele-Specific Knockdown of ALS-Associated Mutant TDP-43 in Neural Stem Cells Derived from Induced Pluripotent Stem Cells. PLoS ONE. 9(3). e91269–e91269. 42 indexed citations
8.
Lee, Youn‐Bok, Han-Jou Chen, João Peres, et al.. (2013). Expanded G4C2 repeats linked to C9ORF72ALS and FTD form length-dependent RNA foci, sequester RNA binding proteins and are neurotoxic. Molecular Neurodegeneration. 8(S1). 6 indexed citations
9.
Chen, Han-Jou, Andrea Chai, Alex Morris, et al.. (2010). Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis. Journal of Biological Chemistry. 285(51). 40266–40281. 138 indexed citations
10.
Sharp, Paul, Mohammed T. Akbar, Sonia Bouri, et al.. (2007). Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiology of Disease. 30(1). 42–55. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026